PHARMA MAR, S.A. «...1617181920...» Page 17 out of 22 28/10/2020 19:27 PHARMA MAR, S.A. On financial instruments Implementation of the reduction of share capital by means of the redemption of own shares approved by the General Shareholders´ Meeting of 18 June 2020 under item number three of the agenda. Register number: 5331 28/10/2020 12:31 PHARMA MAR, S.A. Other relevant information The Company announces the judgement of the General Court of the European Union in relation to the refusal of the marketing authorisation for plitidepsin. Register number: 5307 15/10/2020 08:29 PHARMA MAR, S.A. On business and financial situation PharmaMar signs an agreement with Jazz Pharmaceuticals to commercialize lurbinectedin in Canada Register number: 5026 29/09/2020 19:11 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes - Liquidity and counterparty agreements The company reports the transactions performed in the context of the Share Buy-back Program between 23 September and 25 September 2020. Ending of the Share Buy-back Program and resumption of the liquidity agreement. Register number: 4737 23/09/2020 17:37 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 16 September and 22 September 2020. Register number: 4597 17/09/2020 09:09 PHARMA MAR, S.A. On business and financial situation The Company has presented at the European Society of Medical Oncology (ESMO) Congress new results for lurbinectedin in sensitive patients with Small-Cell Lung Cancer, candidates for “re-challenge Register number: 4478 16/09/2020 17:42 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 9 September and 15 September 2020. Register number: 4468 09/09/2020 17:45 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 2 September and 8 September 2020. Register number: 4339 08/09/2020 07:59 PHARMA MAR, S.A. On business and financial situation The Company announces the creation of a new Virology Unit. Register number: 4263 02/09/2020 17:39 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 26 August and 1 September 2020. Register number: 4185 Page 17 out of 22 «...1617181920...»
